SEARCH

SEARCH BY CITATION

References

  • 1
    Johanson J, Sonnenberg A, Koch T. Clinical epidemiology of chronic constipation. J Clin Gastroenterol 1989; 11(5): 525 36.
  • 2
    Goldfinger S. Constipation, Part 1: The hard facts. Harvard Health Lett 1991; 16(4): 1 3.
  • 3
    Stevens J, et al. Comparison of the effects of psyllium and wheat bran on gastrointestinal transit time and stool characteristics. J Am Diet Assoc 1988; 88: 323 6.
  • 4
    Hamilton JW, et al. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci 1988; 33: 993 8.
  • 5
    Corinaldesi R, et al. Dietary fibers and intestinal transit times. Curr Ther Res 1982; 31: 173.
  • 6
    Marlett JA, et al. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. Am J Gastroenterol 1987; 82: 333 7.
  • 7
    Bass P, et al. Comparison of the laxative efficacy and patient preference of calcium polycarbophil tablets and psyllium suspension. Curr Ther Res 1988; 43: 770.
  • 8
    Borgia M, et al. Controlled study of the effects of two different therapeutic approaches in the treatment of chronic constipation. Clin Ther 1986; 118: 165 70.
  • 9
    Borgia M, et al. Treatment of chronic constipation by a bulk-forming laxative (Fibrolax). J Int Med Res 1983; 11: 124 7.
  • 10
    Burton R & Manninen V. Influence of a psyllium-based fiber preparation on fecal and serum parameters. Acta Med Scand 1982; 668: 91 4.
  • 11
    Chokhavatia S, et al. Comparative laxation of calcium polycarbophil with psyllium mucilloid in an ambulatory geriatric population. Curr Ther Res 1988; 44: 1013.
  • 12
    Zillitto G, et al. Clinical, functional, and metabolic effects of treatment with Plantago ovata seed skins in elderly patients with uncomplicated chronic constipation. Acta Gerontol 1978; 28: 59.
  • 13
    Gilman A, Rall T, Nies A, Taylor, P (eds). The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, Inc., 1983.
  • 14
    Goodman J, Pang J, Bessman A. Dioctyl sodium sulfosuccinate—an ineffective prophylactic laxative. J Chron Dis 1976; 29: 59 63.
  • 15
    Chapman RW, Sillery J, Fontana DD, Matthys C, Saunders DR. Effect of oral dioctyl sodium sulfosuccinate on intake–output studies of human small and large intestine. Gastroenterology 1985; 89: 489 93.
  • 16
    Fain AM, Susat R, Herring M, Dorton K. Treatment of constipation in geriatric and chronically ill patients: a comparison. South Med J 1978; 71: 677 80.
  • 17
    Castle S, Cantrell M, Israel D, Samuelson M. Constipation prevention: Emperic use of stool softeners questioned. Geriatrics 1991; 46(11): 84 6.
  • 18
    Brunton L. Agents affecting gastrointestinal water flux and motility, digestants, and bile acids. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 8th edn, McGraw-Hill, New York, 1997.
  • 19
    Dujovne C & Shoeman L. Toxicity of a hepatic laxative preparation in tissue culture and excretion in bile in man. Clin Pharmacol Ther 1972; 13: 602 8.
  • 20
    O’brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079 87.
  • 21
    Pepple S & McRorie J. Rheological effects of bulk laxatives and a stool softener on luminal contents throughout the large intestine of the pig. Gastroenterology; 110(4): A734(Abstract).
  • 22
    Kumar D, Bartolo D, Devroede G, et al. Symposium on constipation. Int J Colorect Dis 1992; 7: 47 67.